Latest Atorvastatin Stories
The firm is currently offering Lipitor lawsuit evaluations to women who have suffered from allegedly serious Lipitor side effects. (PRWEB) May 13, 2013 The popular statin Lipitor has been the focus of a number of research studies, some of which have found a possible link between the drug and an increased risk of type 2 diabetes in women who use Lipitor to help lower their cholesterol levels, according to Reuters.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on...
The firm is currently offering Lipitor lawsuit evaluations to those who have suffered from allegedly serious Lipitor side effects. (PRWEB) May 09, 2013 For the first time in 55 years, spending on medications in the United States has dropped, in part because of patent expirations for popular drugs such as Lipitor.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what this means for those who seek to file Lipitor lawsuits because they suffered from Lipitor-induced...
Drug manufacturer Merck recently sought and earned U.S. Food and Drug Administration approval for a new drug that pairs its own cholesterol-lowering Zetia with a generic version of Lipitor, the blockbuster statin marketed by Pfizer before it lost patent protection in 2011. The Rottenstein Law Group, which represents clients in Lipitor lawsuits, is watching this development closely, noting that studies have established a link between Lipitor and Type 2 diabetes. (PRWEB) May 07, 2013 Drug...
A recently filed Lipitor diabetes lawsuit alleges that Pfizer was negligent in warning the public about the possible risks associated with developing type 2 diabetes when taking Lipitor. Alonso Krangle is investigating Lipitor type 2 diabetes side effects. New York, NY (PRWEB) April 24, 2013 The defective drug attorneys at Alonso Krangle are investigating Lipitor diabetes lawsuit claims after a Lipitor diabetes lawsuit was filed on behalf of a South Carolina woman who developed type 2...
PRINCETON, N.J., Nov. 28, 2012 /PRNewswire/ -- On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level. The Company is taking this voluntary action as a precautionary measure due to the fact that we cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand (less than 1 mm in size)....
NEW YORK, Aug. 21, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released second quarter 2012 U.S. prescription sales data for the top 100 drugs. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top-selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year's end. Top Five Drugs...
Adding to its numerous research studies, Optimum Clinical Research has started studying a human antibody’s effect on high cholesterol, currently seeking patients for clinical study. SALT LAKE CITY (PRWEB) July 31, 2012 Researchers at Optimum Clinical Research are embarking on a medical study analyzing the effects of a human antibody on high cholesterol. Jared Shields, recruitment coordinator at Optimum Clinical Research, said the study could provide cardiologists a powerful tool to help...
CINCINNATI, July 19, 2012 /PRNewswire/ -- HealthWarehouse.com, Inc. (OTC: HEWA), a leading VIPPS-accredited online retail mail-order pharmacy offers consumers the lowest price of generic Lipitor® in the United States. HealthWarehouse has been selling a generic version of Lipitor® since November 30, 2011. Since May 31, customers have been able to order Atorvastatin at an even greater discount to retail pharmacies without the need for any coupons, discount cards, or insurance....
NEW YORK, July 18, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood-thinners, proton-pump inhibitors, antipsychotics and asthma therapeutic categories continue to remain top sellers. Top Five Drugs by Sales, Q1 2012 Drug Name Sales ($000) % Change (previous quarter) --------- -----------...
FRAMINGHAM, Mass., May 30, 2012 /PRNewswire/ -- Boston Heart Diagnostics (BHD) announced today the commercial launch of the Statin Induced Myopathy (SLCO1B1) Genotype test licensed from the University of Oxford's technology commercialization company Isis Innovation. This adds to the company's IP portfolio and suite of cardiovascular disease (CVD)-focused tests that are designed to improve outcomes for patients and save health dollars by tailoring a therapeutic regimen to the patient's...
